This Pain Medication Could Kill You
October 16, 2007
On September 14, Cephalon Inc. urged U.S. doctors to take special precautions in selecting patients and prescribing the correct dosage of the cancer drug Fentora.
The letter, which was issued in collaboration with the FDA, was in response to the recent deaths of several patients receiving the drug.
Fentora (fentanyl buccal) is a highly potent, opioid pain medication, indicated for use in cancer patients already receiving opioid treatment but who have become tolerant to it. However, doctors are also prescribing Fentora “off-label” for headache and back pain.
According to the FDA, Fentora should also not be used as a substitute for Actiq – another fentanyl product used to treat breakthrough cancer pain – as it may result in a fatal overdose.
Science Daily September 26, 2007
Science Daily September 14, 2007